Sacubitril/Valsartan as an Effective Hypertension Treatment Option in Those With Chronic Type B Aortic Dissection

Am J Hypertens. 2024 Jul 15;37(8):543-545. doi: 10.1093/ajh/hpae054.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Aminobutyrates* / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Aortic Aneurysm / drug therapy
  • Aortic Dissection* / diagnostic imaging
  • Aortic Dissection* / drug therapy
  • Biphenyl Compounds* / therapeutic use
  • Blood Pressure / drug effects
  • Chronic Disease
  • Drug Combinations*
  • Female
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / physiopathology
  • Male
  • Middle Aged
  • Tetrazoles / therapeutic use
  • Treatment Outcome
  • Valsartan* / therapeutic use

Substances

  • Valsartan
  • Aminobutyrates
  • sacubitril and valsartan sodium hydrate drug combination
  • Biphenyl Compounds
  • Drug Combinations
  • Antihypertensive Agents
  • Angiotensin Receptor Antagonists
  • Tetrazoles
  • Angiotensin II Type 1 Receptor Blockers